Fig. 2From: Sequential regression and simulation: a method for estimating causal effects from heterogeneous clinical trials without a common control groupSummary of randomized controlled trial study designs. Data harmonization required careful understanding of the study designs. All treatment arms that involved 8 weeks of consistent exposure to either placebo or (blue) or active treatment at the FDA-approved doses (red) were included. R = randomized and blinded; O = open labelBack to article page